Phibro Animal Health (PAHC) Net Equity Issued and Repurchased (2015 - 2019)

Phibro Animal Health has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $793000.0 in Q1 2019.

• On a quarterly basis, Net Equity Issued and Repurchased fell 50.19% year-over-year to $793000.0 in Q1 2019; TTM through Jun 2019 was $1.1 million, a 80.1% decrease from a year earlier, with the FY2019 full-year figure at $1.1 million, down 80.1% from the prior year.
• Net Equity Issued and Repurchased was $793000.0 for Q1 2019 at Phibro Animal Health, up from $130000.0 in the prior quarter.
• The five-year high for Net Equity Issued and Repurchased was $3.5 million in Q3 2017, with the low at $52000.0 in Q2 2016.
• Average Net Equity Issued and Repurchased over 5 years is $1.2 million, with a median of $718000.0 recorded in 2015.
• The sharpest annual moves came in 2017 and 2018: Net Equity Issued and Repurchased soared 5594.23% in 2017, then plunged 93.95% in 2018.
• Over 5 years, Net Equity Issued and Repurchased stood at $1.4 million in 2015, then tumbled by 96.25% to $52000.0 in 2016, then jumped by 311.54% to $214000.0 in 2017, then tumbled by 39.25% to $130000.0 in 2018, then soared by 510.0% to $793000.0 in 2019.
• The last three Net Equity Issued and Repurchased figures came in at $793000.0 (Q1 2019), $130000.0 (Q4 2018), and $211000.0 (Q3 2018), per Business Quant data.